Fidelity Blue Chip Value ETF (FBCV) Valuation
FBCV valuation today
Holdings combined · company data as of Oct 26, 2026- P/E (TTM)
- 19.4 trailing earnings
- Forward P/E
- 13.9 analyst estimates
- Price / sales
- 1.69
- Price / book
- 3.05
- EV / EBITDA
- 12.4
- Earnings yield
- 5.15% inverse of P/E
- Dividend yield
- 1.57% of the holdings
- Return on equity
- 15.7% combined
- Net margin
- 8.7% combined
- Beta
- 0.82 weighted, vs S&P 500
FBCV valuation vs other stock ETFs
| ETF | P/E | Fwd P/E | P/S | P/B | Div. yield | ROE | Net margin | Loss-makers |
|---|---|---|---|---|---|---|---|---|
| FBCV | 19.4 | 13.9 | 1.69 | 3.05 | 1.57% | 15.7% | 8.7% | 2.6% |
| SPY | 25.9 | 19.9 | 3.67 | 5.47 | 1.08% | 21.1% | 14.2% | 1.9% |
| QQQ | 34.2 | 23.4 | 5.93 | 9.27 | 0.58% | 27.1% | 17.4% | 6.9% |
| DIA | 20.9 | 18.4 | 3.16 | 5.52 | 1.55% | 26.4% | 15.1% | 0.0% |
| VTI | 28.2 | 19.4 | 3.31 | 5.00 | 1.07% | 17.7% | 11.8% | 4.6% |
| IWM | n/m | 13.9 | 1.25 | 2.03 | 1.38% | −1.7% | −1.0% | 28.1% |
Same method for every fund. n/m = not meaningful (combined trailing earnings below zero or close to it). Loss-makers = weight of holdings with negative trailing earnings.
FBCV valuation by sector
| Sector | Weight | P/E | Fwd P/E | P/S | P/B | Div. yield | ROE |
|---|---|---|---|---|---|---|---|
| Financial Services | 17.8% | 13.7 | 11.9 | 2.79 | 2.03 | 1.85% | 14.8% |
| Technology | 16.4% | 24.6 | 17.5 | 2.58 | 6.57 | 0.70% | 26.6% |
| Healthcare | 15.3% | 32.8 | 13.2 | 1.15 | 3.10 | 1.73% | 9.4% |
| Consumer Cyclical | 13.1% | 17.2 | 14.8 | 1.18 | 3.63 | 0.70% | 21.1% |
| Consumer Defensive | 8.1% | 21.8 | 13.8 | 1.23 | 3.41 | 3.17% | 15.6% |
| Energy | 8.1% | 21.6 | 14.0 | 2.24 | 2.48 | 2.30% | 11.5% |
| Industrials | 8.1% | 20.8 | 14.8 | 1.59 | 2.88 | 1.33% | 13.9% |
| Communication Services | 4.6% | 27.7 | 15.3 | 3.20 | 4.66 | 1.12% | 16.8% |
| Basic Materials | 4.0% | 12.0 | 12.5 | 2.68 | 2.69 | 2.26% | 22.4% |
| Utilities | 1.4% | 12.4 | 8.9 | 1.54 | 1.34 | 3.29% | 10.8% |
| Real Estate | 0.6% | 17.7 | 13.6 | 0.78 | 3.03 | 1.62% | 17.1% |
FBCV earnings yield vs bond yields
Earnings yield = earnings ÷ price (1 ÷ P/E). The gap to bond yields is a rough gauge of the extra return stocks are priced to deliver.
How FBCV weight splits by P/E
Share of the covered weight in companies with a trailing P/E in each range.
FBCV largest holdings: valuation
| Symbol | Company | Weight | P/E | Fwd P/E | P/S | Div. yield | Share of earnings |
|---|---|---|---|---|---|---|---|
| AMZN | Amazon.com, Inc. | 6.73% | 20.1 | 23.6 | 3.5 | — | 7.13% |
| MSFT | Microsoft Corporation | 5.50% | 29.5 | 25.1 | 11.8 | 0.74% | 3.98% |
| AAPL | Apple Inc. | 3.61% | 39.4 | 35.2 | 10.7 | 0.31% | 1.95% |
| XOM | Exxon Mobil Corporation | 3.52% | 23.0 | 14.8 | 2.0 | 2.30% | 3.26% |
| BAC | Bank of America Corporation | 2.64% | 12.2 | 10.8 | 3.1 | 2.50% | 4.60% |
| MRK | Merck & Co., Inc. | 2.38% | 115.8 | 15.3 | 5.4 | 2.33% | 0.44% |
| TRV | The Travelers Companies, Inc. | 1.98% | 10.5 | 10.8 | 1.7 | 1.28% | 4.02% |
| KDP | Keurig Dr Pepper Inc. | 1.96% | 35.0 | 12.5 | 2.3 | 2.66% | 1.20% |
| COP | ConocoPhillips | 1.89% | 19.4 | 12.7 | 2.7 | 2.29% | 2.08% |
| L3H | SHELL PLC WI ADR/2 | 1.86% | — | — | — | — | — |
| GILD | Gilead Sciences, Inc. | 1.76% | — | 15.6 | 6.4 | 2.10% | −0.64% |
| WBD | Warner Bros Discovery Inc | 1.56% | — | — | — | — | — |
| AZN | AstraZeneca PLC | 1.53% | — | — | — | — | — |
| META | Meta Platforms, Inc. | 1.47% | 26.7 | 22.1 | 7.9 | 0.30% | 1.17% |
| CB | Chubb Limited | 1.43% | 12.7 | 11.6 | 2.2 | 1.13% | 2.40% |
| UNH | UnitedHealth Group Incorporated | 1.37% | 25.8 | 16.6 | 0.8 | 2.31% | 1.13% |
| NEM | Newmont Corporation | 1.33% | 15.0 | 11.6 | 4.8 | 0.88% | 1.90% |
| CRM | Salesforce, Inc. | 1.30% | 22.0 | 14.0 | 4.5 | 0.73% | 1.26% |
| MTB | M&T Bank Corporation | 1.28% | 11.4 | 10.6 | 3.3 | 2.79% | 2.41% |
| GSK | GSK plc | 1.27% | 15.6 | 9.8 | 3.0 | 3.67% | 1.74% |
| SCHW | The Charles Schwab Corporation | 1.25% | 15.7 | 12.9 | 5.9 | 1.39% | 1.69% |
| PG | The Procter & Gamble Company | 1.22% | 24.1 | 21.2 | 4.3 | 2.73% | 1.08% |
| WFC | Wells Fargo & Company | 1.18% | 11.8 | 10.2 | 3.0 | 2.38% | 2.13% |
| TMO | Thermo Fisher Scientific Inc. | 1.17% | 37.1 | 24.2 | 5.5 | 0.27% | 0.67% |
| DE | Deere & Company | 1.07% | 35.7 | 29.3 | 3.6 | 1.01% | 0.64% |
Share of earnings = the holding's part of the fund's combined trailing profit. Green: earns more than its weight; orange: less. Symbol links go to each company's key metrics.
About FBCV valuation
Adding up its 106 holdings with company data, FBCV trades at 19.4 times trailing earnings and 13.9 times analysts' forward estimates, with a price-to-book ratio of 3.05 and a dividend yield of 1.57%. Its earnings yield of 5.15% is 0.18 percentage points below the 5.33% yield to maturity of the U.S. bond market (AGG).
The ten largest holdings are 32.1% of the fund and earn 28.0% of its combined profit. By sector, Healthcare is the most expensive at 32.8 times earnings and Basic Materials the cheapest at 12.0. Companies that lost money over the past year are 2.6% of the covered weight.
How these figures are calculated. Each ratio treats the fund as one company: the earnings, sales and book value of every holding are added up in proportion to its weight and divided into the fund's price. In practice that is a weighted harmonic mean, so a single stock with a very high P/E cannot distort the result, and loss-making companies reduce the fund's earnings instead of being dropped. Covers 92.6% of the fund's weight (U.S.-listed stocks with company data); company figures as of October 26, 2026.
Related: FBCV chart, FBCV performance, FBCV holdings, FBCV dividends.
FBCV valuation FAQ
What is the P/E ratio of FBCV?
Based on its holdings, FBCV has a trailing P/E of 19.4 and a forward P/E of 13.9 (earnings of all covered holdings combined in proportion to their weights, as of October 26, 2026).
What is the earnings yield of FBCV?
The trailing earnings yield is 5.15% (1 ÷ P/E) and the forward earnings yield 7.19%. For comparison the U.S. bond market (AGG) yields 5.33% to maturity and T-bills about 3.91%.
Is FBCV more expensive than the S&P 500?
FBCV trades at 19.4 times trailing earnings versus 25.9 for the S&P 500 (SPY); on forward estimates the figures are 13.9 and 19.9.
What is the price-to-book ratio of FBCV?
The holdings of FBCV trade at 3.05 times book value, with a combined return on equity of 15.7%.
Which sector in FBCV has the highest P/E?
Healthcare has the highest P/E at 32.8 and Basic Materials the lowest at 12.0.